کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1969705 | 1538906 | 2009 | 6 صفحه PDF | دانلود رایگان |

ObjectivesTo evaluate platelet activating factor (PAF) levels, its metabolic enzymes activity and its associations with other inflammatory markers in heart failure (HF) patients.Design and methodsPAF, and two of its key biosynthetic enzymes [lyso-PAF acetyltransferase (lyso-PAF-AT) and DTT-insensitive CDP-choline:1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase (PAF-CPT)] along with its catabolic enzymes [PAF-acetylhydrolase (PAF-AH) and lipoprotein-associated phospholipase-A2 (Lp-PLA2)] were measured in serum and leukocytes of twelve newly diagnosed male HF patients. Serum CRP, TNF-α, IL-6, sCD14 and CD40L were also determined.ResultsPAF ranged from 0.03 to 5.6 pmol/mL. Median lyso-PAF-AT, PAF-CPT, PAF-AH and Lp-PLA2 activities were 4.1, 68.42, 644.44 pmol/min/mg protein and 51.42 pmol/min/μL correspondingly. Lyso-PAF-AT and PAF-CPT activities positively correlated with CRP, IL-6 and with each other, whereas PAF-CPT activity correlated with sCD14 and CD40L (P < 0.05).ConclusionsPAF's biosynthetic enzyme activities correlated with inflammatory and immunologic molecules, which are activated in HF. Our study indicates a potential role of PAF in HF patients.
Journal: Clinical Biochemistry - Volume 42, Issues 1–2, January 2009, Pages 44–49